23800-56-8
23800-56-8 結(jié)構(gòu)式
基本信息
異香附酮
廣藿香酮對(duì)照品
廣藿香酮(標(biāo)準(zhǔn)品)
廣霍香酮(廣藿香酮)
廣藿香酮(分析標(biāo)準(zhǔn)品)
POGOSTONE 廣藿香酮
4-羥基-6-甲基-3-(4-甲基-1-氧代戊基)-2H-吡喃-2-酮
4-Hydroxy-6-methyl-3-(4-methylpentanoyl)-2H-pyran-2-one
4-Hydroxy-6-methyl-3-(4-methyl-1-oxopentyl)-2H-pyran-2-one
2H-Pyran-2-one,4-hydroxy-6-methyl-3-(4-methyl-1-oxopentyl)-
物理化學(xué)性質(zhì)
| 報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
| 2026/07/06 | S9094 | 廣藿香酮 Pogostone | 23800-56-8 | 1mg | 876.69元 |
| 2026/06/05 | HY-N1416R | 廣藿香酮 Pogostone (Standard) | 23800-56-8 | 5 mg | 945元 |
| 2026/06/05 | HY-N1416R | 廣藿香酮 Pogostone (Standard) | 23800-56-8 | 10 mg | 1521元 |
常見問題列表
IC50: apoptosis; autophagy; bacteria
Pogostone?shows inhibitory effects on HCT116 cell with an IC 50 value of 18.7±1.93 μg/ml, and show strikingly lower cytotoxicity on normal human embryonic kidney cell 293A (IC 50 : 95.13±19.44 μg/ml) and endothelial cell HUVEC (IC 50 : 112±20.77 μg/ml).
Pogostone?( intraperitoneal injection; 25, 50 and 100 mg/kg) shows antibacterial activity in vivo against Escherichia coli (E. coli) and MRSA. Ninety percent of the mice infected with E. coil could be protected at the concentrations of 50 and 100 mg/kg, and 60% of the mice at 25 mg/kg, while the rate of protection for the mice infected with MRSA was 60% and 50% at doses of 100 and 50 mg/kg, respectively.